Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10149)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 19, 2021 (publication date) through Apr 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ľupták M, Michaličková D, Fišar Z, Kitzlerová E, Hroudová J. Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets. World J Psychiatr 2021; 11(7): 277-296 [PMID: 34327122 DOI: 10.5498/wjp.v11.i7.277] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v11/i7/277.htm |
| Number | Citing Articles |
| 1 |
Thian-Sze Wong, Guangzhi Li, Shiliang Li, Wei Gao, Geng Chen, Shiyi Gan, Manzhan Zhang, Honglin Li, Song Wu, Yang Du. G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. Signal Transduction and Targeted Therapy 2023; 8(1) doi: 10.1038/s41392-023-01427-2
|
| 2 |
Shuyang Lin, Bei Gao, Rui Xu, Hongming Shang, Yan Xiong, Jiayi Zhou, Zhe Yang, Chao Jiang, Shumei Yan. Multiple myeloma, IL6, and risk of schizophrenia: A Mendelian randomization, transcriptome, and Bayesian colocalization study. eJHaem 2024; doi: 10.1002/jha2.890
|
| 3 |
Brandon K. Hoglund, Vincent Carfagno, M. Foster Olive, Jonna M. Leyrer-Jackson. Metabotropic Glutamate Receptors in Psychiatric and Neurological Disorders. International Review of Neurobiology 2023; 168: 367 doi: 10.1016/bs.irn.2022.10.004
|
| 4 |
Francesco Matrisciano. Epigenetic regulation of metabotropic glutamate 2/3 receptors: Potential role for ultra-resistant schizophrenia?. Pharmacology Biochemistry and Behavior 2023; 229: 173589 doi: 10.1016/j.pbb.2023.173589
|
| 5 |
Francesco Matrisciano. Functional Nutrition as Integrated Intervention for In- and Outpatient
with Schizophrenia. Current Neuropharmacology 2023; 21(12): 2409 doi: 10.2174/1570159X21666230322160259
|
| 6 |
Zi-long Ma, Run-lan Wang, Lili Meng, Cheng Xin Gong. Construction of a Diagnostic Model and a lncRNA-Associated ceRNA Network Based on Apoptosis-Related Genes for Schizophrenia. Behavioural Neurology 2023; 2023: 1 doi: 10.1155/2023/7017106
|
| 7 |
Inga Dammann, Cathrin Rohleder, F. Markus Leweke. Cannabidiol and its Potential Evidence-Based Psychiatric Benefits
– A Critical Review. Pharmacopsychiatry 2024; doi: 10.1055/a-2228-6118
|
| 8 |
Takeshi Fukushima, Ayano Kansaku, Maho Umino, Tatsuya Sakamoto, Mayu Onozato. Evaluation of D-amino acid oxidase activity in rat kidney using a D-kynurenine derivative, 6-methylthio-D-kynurenine: An <i>in vivo</i> microdialysis study. Drug Discoveries & Therapeutics 2023; 17(6): 434 doi: 10.5582/ddt.2023.01083
|
| 9 |
Zdeněk Fišar. Biological hypotheses, risk factors, and biomarkers of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2023; 120: 110626 doi: 10.1016/j.pnpbp.2022.110626
|
| 10 |
Amritha Harikumar, Kseniya P. Solovyeva, Maria Misiura, Armin Iraji, Sergey M. Plis, Godfrey D. Pearlson, Jessica A. Turner, Vince D. Calhoun. Revisiting Functional Dysconnectivity: a Review of Three Model Frameworks in Schizophrenia. Current Neurology and Neuroscience Reports 2023; 23(12): 937 doi: 10.1007/s11910-023-01325-8
|
| 11 |
I. I. Miroshnichenko. Monitoring of the Antipsychotic Therapy Effectiveness. Psikhiatriya 2023; 20(4): 128 doi: 10.30629/2618-6667-2022-20-4-128-138
|
| 12 |
Alexandre Vallée. Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway. International Journal of Molecular Sciences 2022; 23(5): 2810 doi: 10.3390/ijms23052810
|
| 13 |
Fabio Ferrarelli. Sleep spindles as neurophysiological biomarkers of schizophrenia. European Journal of Neuroscience 2024; 59(8): 1907 doi: 10.1111/ejn.16178
|
| 14 |
Yunfei Tan, Junpeng Zhu, Kenji Hashimoto. Autophagy-related gene model as a novel risk factor for schizophrenia. Translational Psychiatry 2024; 14(1) doi: 10.1038/s41398-024-02767-5
|
| 15 |
Andrea de Bartolomeis, Mariateresa Ciccarelli, Licia Vellucci, Michele Fornaro, Felice Iasevoli, Annarita Barone. Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia. Expert Opinion on Pharmacotherapy 2022; 23(18): 2035 doi: 10.1080/14656566.2022.2145884
|
| 16 |
Magdalena Więdłocha, Natalia Zborowska, Piotr Marcinowicz, Weronika Dębowska, Marta Dębowska, Anna Zalewska, Mateusz Maciejczyk, Napoleon Waszkiewicz, Agata Szulc. Oxidative Stress Biomarkers among Schizophrenia Inpatients. Brain Sciences 2023; 13(3): 490 doi: 10.3390/brainsci13030490
|
| 17 |
Antonio Ventriglio, Annamaria Petito, João Maurício Castaldelli-Maia, Julio Torales, Valeria Sannicandro, Eleonora Milano, Salvatore Iuso, Antonello Bellomo. Use of Psychoeducation for Psychotic Disorder Patients Treated With Modern, Long-Acting, Injected Antipsychotics. Frontiers in Psychiatry 2021; 12 doi: 10.3389/fpsyt.2021.804612
|